InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the full record of transactions filed by Carruthers R Michael, 首席财务官. Officer active across 2 companies, notably Edgewise Therapeutics, Inc.. Cumulatively, 11 disclosures have been recorded. History available since 23 May 2022. The latest transaction was filed on 12 August 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
R. Michael Carruthers is the Chief Financial Officer at Edgewise Therapeutics, Inc. He is responsible for managing the company's finances, including financial planning, risk management, and financial compliance. Carruthers plays a crucial role in financial strategy and the sustainability of the organization.